Dual azithromycin/ceftriaxone therapy for gonorrhoea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold

Research output: Contribution to journalLetter

Original languageEnglish
JournalJournal of Infectious Diseases
ISSN0022-1899
DOIs
Publication statusE-pub ahead of print - 2021

Cite this